학술논문

Population Pharmacokinetics and Exposure–Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON Study
Document Type
Article
Source
In: Clinical Pharmacology and Therapeutics. (Clinical Pharmacology and Therapeutics, December 2023, 114(6):1375-1386)
Subject
Language
English
ISSN
15326535
00099236